CHENNAI: It’s nothing but the dance of mind and machine, where neurons whisper secrets and wires weave dreams. As the digital ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device ...

The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Roche's computational pathology companion diagnostic (CDx) VENTANA TROP2 (EPR20043) RxDx device.

CereVasc announced today that it received FDA breakthrough device designation for its investigational eShunt system.

The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

H.C. Wainwright reiterates a Buy rating and $12 price target on shares of Orchestra BioMed (OBIO) after the company announced that the Food and ...